No photo of Tomasz (Tom) Beer

View Scopus Profile

Tomasz (Tom) Beer

Professor

  • 15948 Citations
  • 56 h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Tomasz (Tom) Beer is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Resistance and Response Mechanisms to Prostate Cancer Therapy

Beer, T. (.

National Institutes of Health

5/1/06 → 3/31/11

Project: Research project

    • A Novel Vitamin D Target in Human Prostate Cancer

    Beer, T. (.

    National Institutes of Health

    3/1/06 → 2/29/08

    Project: Research project

    • Acupuncture for hot flashes in prostate cancer patients

    Beer, T. (.

    National Institutes of Health

    7/14/03 → 9/30/07

    Project: Research project

    • Oregon Prostate Cancer Conference 2001

    Beer, T. (.

    National Institutes of Health

    6/15/01 → 5/31/04

    Project: Research project

    • CALCITRIOL IN RECURRENT PROSTATE CANCER

    Beer, T. (. & Henner, W.

    National Institutes of Health

    9/30/99 → 9/29/03

    Project: Research project

    • Research Output

    A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide alone

    Graff, J. N., Beer, T. M., Alumkal, J. J., Slottke, R. E., Redmond, W. L., Thomas, G. V., Thompson, R. F., Wood, M. A., Koguchi, Y., Chen, Y., Latour, E., Bergan, R. C., Drake, C. G. & Moran, A. E., Jul 2 2020, In : Journal for immunotherapy of cancer. 8, 2, e00642.

    Research output: Contribution to journal › Article

    Open Access

    • Association between New Unconfirmed Bone Lesions and Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials

    Armstrong, A. J., Al-Adhami, M., Lin, P., Parli, T., Sugg, J., Steinberg, J., Tombal, B., Sternberg, C. N., De Bono, J., Scher, H. I. & Beer, T. M., Feb 2020, In : JAMA Oncology. 6, 2, p. 217-225 9 p.

    Research output: Contribution to journal › Article

    Open Access
    • 2 Scopus citations

    Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancer

    Kwon, D. H., Zhang, L., Quigley, D. A., Foye, A., Chen, W. S., Wong, C. K., Feng, F. Y., Bailey, A., Huang, J., Stuart, J. M., Friedl, V., Weinstein, A. S., Beer, T. M., Alumkal, J., Rettig, M., Gleave, M., Lara, P. N., Thomas, G. V., Li, P., Lui, A. & 2 others, Small, E. J. & Aggarwal, R. R., 2020, (Accepted/In press) In : Urologic Oncology: Seminars and Original Investigations.

    Research output: Contribution to journal › Article

    • Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors

    for the CA184-043, Investigators, 2020, (Accepted/In press) In : European Urology.

    Research output: Contribution to journal › Article

    • Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL Trial

    Armstrong, A. J., Lin, P., Tombal, B., Saad, F., Higano, C. S., Joshua, A. M., Parli, T., Rosbrook, B., van Os, S. & Beer, T. M., Sep 2020, In : European Urology. 78, 3, p. 347-357 11 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations